Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
04/2012
04/24/2012CA2425599C Fumaric acid amides
04/19/2012WO2012051431A2 Compositions and methods for treating endocrine, gastrointestinal or autoimmune disorders
04/19/2012WO2012051318A1 Sulphonamide compounds and methods of making and using same
04/19/2012WO2012051107A2 Niacin formulations and methods with reduced flushing side-effect
04/19/2012WO2012050695A1 Use of lysosomal acid lipase for treating lysosomal acid lipase deficiency in patients
04/19/2012WO2012050500A1 1,2-dihydro-4-hydroxy-2-oxo-quinoline-3-carboxanilides as ahr activators.
04/19/2012WO2012050162A1 Cellular life span extending agent, and telomerase activator
04/19/2012WO2012050151A1 Acylbenzene derivative
04/19/2012WO2012049566A1 Combination therapy for use in treating diabetes
04/19/2012WO2012048414A1 A method of regulating plasma lipoproteins
04/19/2012WO2012021013A3 Novel biphenyl compound or pharmaceutically acceptable salt thereof, method for preparing novel biphenyl compound or pharmaceutically acceptable salt thereof, and pharmaceutical composition containing same as active ingredient for preventing or treating diabetes complications
04/19/2012WO2012015168A3 Pharmaceutical composition comprising rosuvastatin or a pharmaceutically acceptable salt thereof
04/19/2012WO2011163533A4 One step removal of selected molecules from body fluid and tissue
04/19/2012WO2011159067A3 Thiazole derivatives as sglt2 inhibitors and pharmaceutical composition comprising same
04/19/2012WO2011156736A3 Targeted mucosal treatment of obesity and diabetes
04/19/2012WO2011155705A3 Composition for inhibiting hyperlipidemia and obesity by inhibiting intestinal absorption of cholesterol
04/19/2012WO2011153525A9 Methods for treatment of nephrotic syndrome and related conditions
04/19/2012WO2011153491A3 Agonists of growth hormone releasing hormone as effectors for survival and proliferation of pancreatic islets
04/19/2012WO2011152692A3 Anti-obesity cream composition containing fucoxanthin
04/19/2012WO2011152689A3 Method for purifying fucoxanthin derived from seaweed
04/19/2012WO2011149766A3 Lipid-tailored pharmaceutical agents
04/19/2012WO2011149301A3 A composition comprising the extract of physalis alkekengi var. francheti hort as an active ingredient for preventing and treating inflammatory diseases
04/19/2012WO2011146518A9 Pegylated c-peptide
04/19/2012WO2011144674A3 PHARMACEUTICAL FORMULATION COMPRISING INSULIN GLARGINE AND SBE4-ß-CYD
04/19/2012WO2011140208A3 Methods and compositions for diagnosing and treating autoimmune disorders
04/19/2012WO2011136573A3 Yeast hydrolysate having obesity treatment effects and antioxidant activity
04/19/2012WO2011130618A3 Compositions and methods for producing glycosylated human pdx-1 protein and methods of use therefore
04/19/2012WO2011127393A3 Variants of ancestral uricases and uses thereof
04/19/2012US20120096569 Anti-il-6 antibodies,compositions, methods and uses
04/19/2012US20120095102 Salts of 3-Pentylphenylacetic Acid and Pharmaceutical Uses Thereof
04/19/2012US20120095091 Antiepileptic, hypocholesterolemic and neuroprotective compound
04/19/2012US20120095081 Treatment of paraoxonase 1 (pon1) related diseases by inhibition of natural antisense transcript to pon1
04/19/2012US20120095074 Genetic Alterations on Chromosome 12 and Methods of Use Thereof for the Diagnosis and Treatment of Type 1 Diabetes
04/19/2012US20120095072 Crystalline Sodium Atorvastatin
04/19/2012US20120095071 3-(3-indolyl) propionic acid calcium salt and method of making 3-(3-indolyl) propionic acid free acid therefrom
04/19/2012US20120095063 Methods and compositions for treatment of ischemic conditions and conditions related to mitochondrial function
04/19/2012US20120095059 Compositions and Methods for Treating Type II Diabetes and Related Disorders
04/19/2012US20120095056 2,5-disubstituted tetrazole derivatives and their use as nicotinic acetylcholine receptor modulators
04/19/2012US20120095055 HEXAHYDROCYCLOPENTYL[f]INDAZOLE 5-HYDROXYMETHYL ETHANOLS AND DERIVATIVES THEREOF AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS
04/19/2012US20120095049 Nociceptin analogs
04/19/2012US20120095047 Novel Heteropyrrole Analogs Acting on Cannabinoid Receptors
04/19/2012US20120095046 Amido-Isothiazole Compounds and Their Use as Inhibitors of 11Beta-HSD1 for the Treatment of Metabolic Syndrome and Related Disorders
04/19/2012US20120095043 Triglyceride-lowering agent and hyperinsulinism-ameliorating agent
04/19/2012US20120095028 3-oxa-7-azabicyclo[3.3.1]nonanes
04/19/2012US20120095025 SUBSTITUTED [1,2,4]TRIAZOLO[1,5-a]PYRIMIDINES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS
04/19/2012US20120095005 Fused Bicyclic Pyrazole Derivatives As Kinase Inhibitors
04/19/2012US20120095001 Substituted-1,3,8-triazaspiro[4.5]decane-2,4-diones
04/19/2012US20120094996 Imidazo [2, 1-B] [1, 3, 4] Thiadiazole Derivatives
04/19/2012US20120094993 N-pyridin-3-yl or n-pyrazin-2-yl carboxamides
04/19/2012US20120094992 Poly (adp-ribose) polymerase (parp) inhibitors
04/19/2012US20120094987 SUBSTITUTED PYRIDO [3', 2': 4, 5] THIENO [3, 2-D] PYRIMIDINES AND PYRIDO [3', 2': 4, 5] FURO [3, 2-D] PYRIMIDINES USED AS INHIBITORS OF THE PDE-4 AND/OR THE RELEASE OF TNF-alpha
04/19/2012US20120094979 Thiazole or thiadizaloe derivatives for use as sphingosine 1-phosphate 1 (s1p1) receptor agonists
04/19/2012US20120094973 Catechol-based derivatives for treating or preventing diabetics
04/19/2012US20120094970 NON-HORMONAL STEROID MODULATORS OF NF-kB FOR TREATMENT OF DISEASE
04/19/2012US20120094960 Dosage forms of risedronate
04/19/2012US20120094958 Quinolines as inhibitors of farnesyl pyrophosphate synthase
04/19/2012US20120094944 Novel imidazopyridine compound
04/19/2012US20120094942 Chemosensory Receptor Ligand-Based Therapies
04/19/2012US20120094941 Mangiferin-Berberine Salt, Manufacturing Method and Use Thereof
04/19/2012US20120094940 Process of producing sugar composition comprising definite amount of target hexose and having sugar constitution different from that of starting sugar material and use of produced sugar composition
04/19/2012US20120094934 Treatment of tumor necrosis factor receptor 2 (tnfr2) related diseases by inhibition of natural antisense transcript to tnfr2
04/19/2012US20120094908 Truncated activin type ii receptor and methods of use
04/19/2012US20120094905 Method for Treating Hyperglycemia with GLP-1
04/19/2012US20120094904 Fad4, fad5, fad5-2, and fad6, novel fatty acid desaturase family members and uses thereof
04/19/2012US20120094903 Compositions for intranasal delivery of human insulin and uses thereof
04/19/2012US20120094902 Fast-acting insulin formulation
04/19/2012US20120094899 Neuromedin u derivative
04/19/2012US20120094898 Peptide derivative
04/19/2012US20120094894 Antidiabetic medications comprising a dpp-4 inhibitor (linagliptin) optionally in combination with other antidiabetics
04/19/2012US20120094293 PGC-1ß, A NOVEL PGC-1 HOMOLOGUE AND USES THEREFOR
04/19/2012US20120093940 Medical food or nutritional supplement for managing blood glucose levels and method of manufacturing same
04/19/2012US20120093936 Method and device for treatment of conditions associated with inflammation or undesirable activation of the immune system
04/19/2012US20120093933 Denatured lactoglobulin and polyphenol coassemblies
04/19/2012US20120093924 Methods of treating hypertriglyceridemia
04/19/2012US20120093923 Apparatus And Methods For Delivering A Plurality Of Medicaments For Management Of Co-Morbid Diseases, Illnesses, Or Conditions
04/19/2012US20120093922 Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
04/19/2012US20120093898 Metal Ion Nanoclusters
04/19/2012US20120093889 Layered pharmaceutical formulations
04/19/2012US20120093885 Therapeutic vesicles
04/19/2012US20120093883 Method of treating and preventing neuro-olfactory triggered or aggravated illnesses or related conditions
04/19/2012US20120093878 Pharmaceutical compositions containing a biguanide and a thiazolidinedione
04/19/2012US20120093875 Aminocyclitol compounds, process for obtaining them and uses
04/19/2012US20120093832 Promotion of neuronal integration in neural stem cell grafts
04/19/2012US20120093815 Fgf21 mutants and uses thereof
04/19/2012US20120093796 Novel use of ec-sod and method for preparing thereof
04/19/2012US20120093794 Methods for Treating Pompe Disease
04/19/2012US20120093785 Human artificial chromosome (hac) vector
04/19/2012US20120093779 Complex microbial preparation for treating diabetes and preparative method and use thereof
04/19/2012US20120093770 Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
04/19/2012US20120093764 Treatment of diabetes using g-csf and hyperbaric oxygen
04/19/2012US20120093759 Medical Devices, Wound Dressings, and Methods for Dressing Wounds
04/19/2012US20120091605 Chewable Soft Capsule
04/19/2012US20120090604 Synthesis of small particles
04/19/2012CA2814698A1 Compositions and methods for treating endocrine, gastrointestinal or autoimmune disorders
04/19/2012CA2814628A1 Acylbenzene derivative
04/19/2012CA2814413A1 Sulphonamide compounds and methods of making and using same
04/19/2012CA2813750A1 Method for treating cystic fibrosis with inhaled denufosol
04/19/2012CA2813711A1 1,2-dihydro-4-hydroxy-2-oxo-quinoline-3-carboxanilides as ahr activators.
04/19/2012CA2812909A1 Compositions and methods for augmenting kidney function
04/19/2012CA2812657A1 A method of regulating plasma lipoproteins
1 ... 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 ... 1298